Natco Pharma Tummala Venkata Rao supperannuates as Vice President - Production
Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company.
"With effect from the closure of business hours on 31st March, 2025, Mr. Tummala Venkata Rao has superannuated and shall cease to be the Vice President – Production of the Company," Natco stated in a BSE filing.
NATCO Pharma Limited, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. The Company is a R&D oriented, and a science driven, leading Oncology player in the targeted therapies of domestic market and focuses on limited competition molecule in the US. The Company has 9 manufacturing sites and 2 R&D facilities in India. The Company’s manufacturing facilities are approved by several leading regulatory authorities like US FDA, Brazil ANVISA, Health Canada, WHO and others catering to 50+ global markets.
